Compare Travere Therapeutics Inc. Common Stock (TVTX) vs Vanguard Information Technology Index Fund ETF (VGT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Travere Therapeutics Inc. Common Stock vs Vanguard Information Technology Index Fund ETF — how do they compare? Travere Therapeutics Inc. Common Stock trades at $52.74 (market cap $4.88B), while Vanguard Information Technology Index Fund ETF trades at $121.92 (market cap $170.20B). The key difference: Vanguard Information Technology Index Fund ETF is far larger — about 34.9× Travere Therapeutics Inc. Common Stock's market cap, and Vanguard Information Technology Index Fund ETF is trading nearer its 52-week high, Travere Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Travere Therapeutics Inc. Common Stock for 0 Days and Vanguard Information Technology Index Fund ETF for 130 Days on average.
| TVTX | VGT | |
|---|---|---|
Market Cap | $4.88B | $170.20B |
Volume | 1,668,577 | 2,835,027 |
Sector | Health | — |
52-Week High | $67.52 | $129.79 |
52-Week Low | $26.79 | $83.59 |
Typical Hold Time | 0 Days | 130 Days |
Enterprise Value | $5.01B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Travere Therapeutics (TVTX) trades at $51.80, down 0.42% on the day, with a neutral technical signal. The company reported strong revenue growth but persistent net losses, with a 2025 net income margin of -7.35%. Recent news includes new data presentations for its key drug FILSPARI and a CEO transition. Analyst consensus is strongly bullish with an 83.33% buy rating and a $70.60 price target, suggesting significant upside from the current price.
The outlook for TVTX hinges on the commercial success of FILSPARI, which shows promising sales growth, but profitability remains a challenge. Key risks include execution of the CEO transition, competitive pressures in nephrology treatments, and the company's ability to achieve sustained profitability. The high valuation multiples relative to negative earnings present a risk-reward balance for investors.
Vanguard Information Technology ETF (VGT) trades at $126.48, down 0.02% on the day, with a bullish technical signal from moving averages and neutral oscillators. The ETF, focused on U.S. technology stocks, lacks key valuation ratios in the provided data but has demonstrated strong historical performance, with news highlighting past annualized returns exceeding 17% over two decades. Recent articles emphasize its low expense ratio and concentration in top tech holdings like Nvidia, Apple, and Microsoft.
The outlook for VGT remains positive given technology sector growth and AI-driven momentum, but risks include high concentration in a few stocks and sensitivity to tech sector volatility. Long-term investors may benefit from its historical outperformance, though diversification and expense ratios compared to peers like IYW or QQQ warrant consideration.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Travere Therapeutics Inc. Common Stock
Travere Therapeutics Inc. is a biopharmaceutical company focused on rare kidney and metabolic diseases. Its lead product, FILSPARI (sparsentan), is an oral medication for adults with IgA nephropathy, and it also markets Thiola for cystinuria.
Read more on TVTX →About Vanguard Information Technology Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index/Information Technology 25/50, an index made up of stocks of large, mid-size, and small US companies within the information technology sector, as classified under the GICS. The advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VGT →
